Literature DB >> 8892524

Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasians.

D Lucas1, C Ménez, F Floch, Y Gourlaouen, O Sparfel, I Joannet, P Bodénez, J Jezequel, H Gouérou, F Berthou, L G Bardou, J F Ménez.   

Abstract

Genetic polymorphisms of various cytochromes P450 have recently been described and could be implicated in the individual susceptibility of alcoholics to ethanol-related diseases. Rsal and Dral polymorphisms of CYP2E1 and Mspl polymorphism of CYP1A1 were studied in 260 controls and 511 alcoholic patients, without any clinical symptoms (n = 202) or with various ethanol-related diseases (n = 309), such as liver cirrhosis (n = 110), esophageal cancer (n = 62), upper aerodigestive tract cancer (n = 96), and other miscellaneous diseases (n = 41). Frequencies of the mutated alleles were found to be 2.5% (Rsal), 7.9% (Dral), and 8.7% (Mspl) in controls; 4%, 14.1%, and 12% in alcoholics without clinical symptoms; and 3.1%, 12.5%, and 11.2% in alcoholics with ethanol-related diseases. The only significant difference was found in the Dral polymorphism, whose frequency was enhanced in alcoholics with (p < 0.05) or without ethanol-related diseases (p < 0.01) when compared with controls. No differences were found between alcoholics without clinical symptoms and alcoholics with cirrhosis, esophageal cancer, or upper aerodigestive tract cancer. However, in liver cirrhosis and in ethanol-related cancers, the rare Dral-C allele was three times less frequent in patients under the age of 45 than in older patients, suggesting a protective role for this allele. In conclusion, our data indicate that the aforementioned mutations do not play a critical role in the development of cirrhosis, esophageal cancer, or upper aerodigestive tract cancers in Caucasians.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892524     DOI: 10.1111/j.1530-0277.1996.tb01943.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

1.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Authors:  N A Wong; F Rae; K J Simpson; G D Murray; D J Harrison
Journal:  Mol Pathol       Date:  2000-04

2.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Authors:  S Liu; J Y Park; S P Schantz; J C Stern; P Lazarus
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

3.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

4.  Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.

Authors:  Chun-Xia Yang; Keitaro Matsuo; Zhi-Ming Wang; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.

Authors:  Yuming Niu; Hua Yuan; Weidong Leng; Yongchu Pang; Ning Gu; Ning Chen
Journal:  Med Oncol       Date:  2010-03-02       Impact factor: 3.064

6.  Alcohol consumption and corresponding factors: A novel perspective on the risk factors of esophageal cancer.

Authors:  Qiao Peng; Hui Chen; Ji-Rong Huo
Journal:  Oncol Lett       Date:  2016-04-01       Impact factor: 2.967

7.  Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis.

Authors:  Tao Zeng; Fang-Fang Guo; Cui-Li Zhang; Fu-Yong Song; Xiu-Lan Zhao; Ke-Qin Xie
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

8.  The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.

Authors:  Kefu Tang; Yang Li; Zhao Zhang; Yunmin Gu; Yuyu Xiong; Guoyin Feng; Lin He; Shengying Qin
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

9.  Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis.

Authors:  Florence Trivin; Eveline Boucher; Elodie Vauléon; Isabelle Cumin; Elisabeth Le Prisé; Odile Audrain; Jean-Luc Raoul
Journal:  J Oncol       Date:  2009-12-22       Impact factor: 4.375

10.  Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.

Authors:  Wei-Dong Leng; Xian-Tao Zeng; Yong-Ji Chen; Xiao-Li Duan; Yu-Ming Niu; Rong-Pei Long; Zhi-Xiao Luo
Journal:  Exp Ther Med       Date:  2012-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.